SCHEMBL14440752

SCHEMBL14440752

Nc1cc(C(F)(F)F)ccc1C(=O)N1CCS(=O)(=O)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 3/20 0.55
FEN1 P39748 3/20 0.55
HPGD P15428 3/20 0.54
ALDH1A1 P00352 2/20 0.54
KDM4E B2RXH2 1/20 0.54
HSD17B10 Q99714 1/20 0.54
CFTR P13569 1/20 0.49
SCN9A Q15858 1/20 0.42
EPHX2 P34913 3/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TSHR P16473 1/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.40
MAPK1 P28482 1/20 0.40
HRH4 Q9H3N8 1/20 0.40
L3MBTL3 Q96JM7 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5497253 0.86 HPGD (0.59) HPGDALDH1A1KDM4EHSD17B10CFTR
SCHEMBL3898498 0.85 HPGD (0.59) HPGDALDH1A1KDM4EHSD17B10CFTR
SCHEMBL4506790 0.82 EPHX2 (0.57) ALOX5APFEN1HPGDALDH1A1KDM4E
SCHEMBL14468039 0.80 HPGD (0.52) ALOX5APFEN1HPGDALDH1A1KDM4E
SCHEMBL15688104 0.79 KDM4E (0.51) HPGDALDH1A1KDM4EHSD17B10CFTR
SCHEMBL14440750 0.79 ALOX5AP (0.46) ALOX5APFEN1ALDH1A1SCN9AEPHX2
SCHEMBL12382105 0.74 HIF1A (0.51) ALOX5APFEN1HPGDKDM4EHSD17B10
SCHEMBL23748561 0.73 CPS1 (0.48) ALOX5APFEN1HPGDKDM4EEPHX2
SCHEMBL15916366 0.72 ALOX5AP (1.00) ALOX5APFEN1
SCHEMBL955863 0.71 ALDH1A1 (1.00) HPGDALDH1A1KDM4EHSD17B10CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185098-A1 Inhibitors of protein kinases LOCUS PHARMACEUTICALS, INC. (US) 2007-08-09 US disclosed
US-20070185098-A1 Inhibitors of protein kinases LOCUS PHARMACEUTICALS, INC. (US) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185098-A1 Inhibitors of protein kinases MAP3K20, MAP3K1, MAP3K19 ALOX5AP 3834/4885FEN1 3559/4885HPGD 2153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.